Elevance Health (NYSE: ELV) will announce its earnings on Thursday, July 17, 2025, with analysts expecting earnings of $9.19 per share and revenue of $48.26 billion. This is a decrease from the same quarter last year, when the company reported earnings of $10.12 per share on revenue of $43.22 billion.
Over the past five years, Elevance has had positive one-day stock returns in 55% of the instances following earnings reports, with a median return of 2.7% and a maximum return of 7.7%. The company currently holds a market capitalization of $77 billion and reported $183 billion in revenue with a net income of $5.9 billion over the last twelve months.
